Colonic organoids + pyrogallol-conjugated intestine-derived extracellular matrix
Colonic organoids + pyrogallol-conjugated intestine-derived extracellular matrix has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Sep 15, 2026: “A self-crosslinkable, adhesive intestine-derived extracellular matrix hydrogel enhances organoid retention and restores intestinal barrier integrity”.
1 paper studies it1 findingUpdated
See all 1 papers on colonic organoids + pyrogallol-conjugated intestine-derived extracellular matrix
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
- 1 lab in 1 country
- Funders: Korea Research Institute of Bioscience & Biotechnology and 3 more
- 1 of 1 finding with company ties
- Animals1
What did studies of colonic organoids + pyrogallol-conjugated intestine-derived extracellular matrix find?
1Studies of colonic organoids + pyrogallol-conjugated intestine-derived extracellular matrix measured one outcome, intestinal barrier integrity.
Intestinal barrier integrity
upin mice1
1 study
Intestinal barrier integrity
upin mice1
Colonic organoids + pyrogallol-conjugated intestine-derived extracellular matrix improves intestinal barrier integrity in mice (mouse colonic ulcer model).
“demonstrated effective cell retention in the intestinal tract, thereby restoring the structural integrity and function of the intestinal barrier.”
Animalsmouse colonic ulcer model
Bioactive materials